Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
CAMBRIDGE, Mass., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced the...
Macrocure and Leap Therapeutics Complete Merger PR Newswire PETACH TIKVA, Israel, January 23, 2017 PETACH TIKVA, Israel, January 23, 2017 /PRNewswire/ -- Macrocure Ltd. (NASDAQ: MCUR), a...
Durable responses observed in patients with Wnt-pathway genetic mutations CAMBRIDGE, Mass., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. reported updated clinical and biomarker...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of The Board of Directors of Macrocure Ltd.- MCUR PR Newswire NEW YORK, Nov. 29, 2016 NEW YORK, Nov. 29, 2016...
Macrocure Announces New Date for Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics PR Newswire PETACH TIKVA, Israel, November 25, 2016 PETACH TIKVA, Israel...
Macrocure Announces Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics PR Newswire PETACH TIKVA, Israel, Nov. 7, 2016 PETACH TIKVA, Israel, Nov. 7, 2016 /PRNewswire/...
Leap Therapeutics and Macrocure Announce Definitive Merger Agreement Combined company to advance Leap's two first-in-class immuno-oncology monoclonal antibodies targeting aggressive cancers PR...
Macrocure Files Annual Report on Form 20-F for the Year Ended December 31, 2015 PR Newswire PETACH TIKVA, Israel, April 20, 2016 PETACH TIKVA, Israel, April 20, 2016 /PRNewswire/ -- Macrocure...
Macrocure Announces Receipt of NASDAQ Minimum Bid Price Notification PR Newswire PETACH TIKVA, Israel, April 11, 2016 PETACH TIKVA, Israel, April 11, 2016 /PRNewswire/ -- Macrocure Ltd. (NASDAQ:...
PETACH TIKVA, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (NASDAQ:MCUR), a clinical-stage biotechnology company, today announced that it will hold its Annual General Meeting of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
